Darolutamide User Reviews & Ratings
Brand names: Nubeqa
Darolutamide has an average rating of 10.0 out of 10 from a total of 2 reviews on Drugs.com. 100% of reviewers reported a positive experience, while 0% reported a negative experience.
| Condition | Avg. Rating | Reviews | Compare |
|---|---|---|---|
| Prostate Cancer | 2 reviews for Prostate Cancer | 59 medications | |
| Add your review | |||
- Fred
- Taken for 1 to 6 months
- March 4, 2024
For Prostate Cancer "I've been taking it since October. My PSA was at 117, went to 30 in one month, 19 next month, then 6, 3, 1.6, and now, 5 months later it's 0.73. Minor side effects including swollen ankles and hot flashes. Very pleased with the results."
Reviews may be edited to correct grammar/spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest are not published. This information is not intended to endorse any particular medication. While these reviews may be helpful, they are not a substitute for the expertise, knowledge, and judgement of healthcare professionals.
More about darolutamide
- Check interactions
- Compare alternatives
- Reviews (2)
- Side effects
- Dosage information
- During pregnancy
- Drug class: antiandrogens
- En español
Nubeqa (darolutamide) for Prostate Cancer "I have been taking Nubeqa for 3 years now. Started taking as a result of my prior treatment with just Lupron Depot injections becoming much less effective. Nubeqa along with Lupron Depot lowered my PSA from an increasing 2.675 to 0.240 in 2 months time and lowered it again to 0.086 after another 2 months time. The same treatment of Nubeqa along with a Lupron Depot injection has kept my PSA below 0.01 for 3 years now. No noticeable side effects or interactions with my BP meds. It is very expensive but I applied for co-pay assistance which along with my Medicare coverage has lowered my copay to 0."